IMPACT OF SLEEP QUALITY AND DAY SLEEP IN PATIENTS WITH DIABETES MELLITUS AND BLOOD HYPERTENSION
DOI:
https://doi.org/10.18041/2390-0512/biociencias.1.5322Keywords:
Quality of sleep, daytime sleepiness, Diabetes, Arterial HypertensionAbstract
Objective: To evaluate the quality of nocturnal sleep and daytime sleepiness in patients diagnosed with diabetes mellitus and arterial hypertension. Methods: A prospective, cross-sectional study was conducted in patients older than 18 years diagnosed with diabetes mellitus and arterial hypertension, according to the ADA 2016 and ESH / ESC, who attend the internal medicine clinic of the "Dr. Miguel Pérez Carreño "in the period from January to July 2017.Results: 263 were evaluated, with female predominance with 63.1%; with an age range of 19-92 years, an average of 61 years ± 13. The Berlin questionnaire was applied to estimate the risk of OSAS, evidencing 56.27% low risk and 43.7% high risk; overweight patients had 27% and obese patients 21.7% at high risk. Poor sleep quality was observed in 79.8% of hypertensive patients and 95.5% in diabetic patients. Daytime sleepiness in hypertensive patients was 47.2%, and in diabetics 45.4%. There was a high risk of OSAS in hypertensive patients, 47.9%, in diabetics, 40.9%. It was determined that there was no relationship between hypertension and DM with poor sleep quality (p = 0.186), daytime sleepiness (0.627) and OSAS (p = 0.208). Conclusions: The poor quality of sleep was present in the majority of the population and the presence of daytime sleepiness was lower. There was a high risk of OSAS in relation to body mass index and alcohol habit.
Downloads
References
2. Talero C, Durán F, Pérez I. Sueño: características generales. Patrones fisiológicos y fisiopatológicos en la adolescencia. Rev Cienc Salud 2013; 11 (3): 333-348.
3. Navarrete R., Cambios Fisiológicos en el Sueño.Servicio de Neurología, Hospital “Teodoro Maldonado Carbo” de Rev. Ecuat. Neurol, 2013,22(1-3): 60-67.
4. Csige I, Ujvárosy D, Szabó Z, Lőrincz I, Paragh G, Harangi M. The Impact of Obesity on the Cardiovascular System. J Diabetes Res. 2018 Nov 4; 2018:3407306. doi: 10.1155/2018/3407306.
5. Chasens E, Korytkowski M, Sereika S, Burke L, Effect of Poor Sleep Quality and Excessive Daytime Sleepiness on Factors Associated with Diabetes Self-Management, Diabetes Educ. 2013 ; 39(1): 74-82. doi: 10.1177/0145721712467683.
6. Classification and Diagnosis of Diabetes. Diabetes Care 2016; 39(Suppl. 1):S13 - S22. DOI: 10.2337/dc16-S005.
7. 2013 ESH/ESC Guidelines for the management of arterial hypertension. European Heart Journal. 2013; 34(28):2159-2219.
8. Belo M., Zanetti M, Calidad Del Sueño En Diabéticos Tipo 2, Rev Latino-am Enfermagem 2008 setembro-outubro; 16(5).
9. Cappuccio F, Cooper D, Lanfranco D. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies European Heart Journal, 2011; 32: 1484–1492 doi:10.1093/eurheartj/ehr007.
10. Aziz, M; Sali S, Das, S; Younus, A; Malik, R; Association of subjective and objective sleep duration as well as sleep quality with non invasive markers of subclinical cardiovascular disease: a systematic review; J atheroscler Thromb; 2016; 23: 000-000. doi: 10.5551/jat.36194
11. Asplund R. Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly. BJU Int 2002 August; 90(6):533-6.
12. Castillo J,Araya F, Montecino L, Torres C, Aplicación de un cuestionario de sueño y la escala de somnolencia de Epworth en un centro de salud familiar. Rev Chil Neuro-Psiquiat 2008; 46 (3): 182-191. doi.org/10.4067/S0717-92272008000300003
13. Ehlers CL, Gilder DA, Criado JR, Caetano R. Sleep quality and alcohol-use disorders in a select population of young-adult Mexican Americans. J Stud Alcohol Drugs. 2010 Nov; 71(6):879-84.
14. Ehlers, C.L., Wills, D. & Gilder, D.A. Psychopharmacology (2018) 235: 1775.https://doi.org/10.1007/s00213-018-4889-5.
15. Jean-Louis G, Williams NJ, Sarpong D, Pandey A, Youngstedt S, Zizi F, Ogedegbe G. Associations between inadequate sleep and obesity in the US adult population: analysis of the national health interview survey (1977-2009). BMC Public Health, 2014; 14:290. doi: 10.1186/1471-2458-14-290.
16. Ohayon MM. Determining the level of sleepiness in the American population and its correlates. J Psychiatr Res 2012; 46:422–7. doi: 10.1016/j.jpsychires.2011.06.008.
17. Watson NF, Harden KP, Buchwald D, Vitiello MV, Pack AI, Weigle DS. Sleep duration and body mass index in twins: a gene-environment interaction. Sleep. 2012 May 1; 35(5): 597–603. doi: 10.5665/sleep.1810.
18. Lacedonia D, Carpagnano GE, Patricelli G, Carone M, Gallo C, Caccavo I, Sabato R. Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome. Clin Respir J. 2018 May; 12(5):1905-1911. doi: 10.1111/crj.12754.
19. Romdhane H, Ayadi S, Cheikh M, Bouchabou B, Ben Nejma H, Ennaifer R. Estimation of the prevalence of obstructive sleep apnea in non alcoholic fatty liver disease. Tunis Med. 2018 Apr;96(4):171-176.
20. Chen Y, Xiong L1, Zeng J, Wei YG, Tan Y. Gastroesophageal reflux disease is associated with high risk of obstructive sleep apnea syndrome. Chinese J Intern Med. 2018 Nov 1;57(11):824-829. doi: 10.3760/cma.j.issn.0578-1426.2018.11.006.
